7-substituted tetracycline compounds
US6818635B2 · kind B2 · utility
84Cited by
16References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 29, 2001 |
| Grant date | Nov 16, 2004 |
| Priority date | — |
| Expiry date | Jun 29, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention pertains, at least in part, to novel 7-substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.